Hepcidin mimetic peptides and uses thereof
AssigneeMerganser Biotech, Inc.
InventorGene Scott Merutka
Life of this patent
Estimating the term…
Abstract
Compounds and methods are described herein that can be used to treat subjects for conditions related to hepcidin activity, such as but not limited diseases of iron metabolism, beta thalassemia, hemochromatosis, iron-loading anemias, alcoholic liver disease, or chronic hepatitis C.
Claims13
A compound, or pharmaceutically acceptable salt thereof, of formula
- wherein R1 is —S—CH3 or H.
A pharmaceutical composition comprising a compound, or pharmaceutically acceptable salt thereof, of formula
- wherein R1 is —S—CH3 or H.
A method of reducing serum iron concentration in a subject in need thereof comprising administering to the subject a pharmaceutical composition comprising a compound, or pharmaceutically acceptable thereof, of formula
- wherein R1 is —S—CH3 or H.
A method of therapeutic treatment for beta thalassemia comprising administering to a subject in need thereof a pharmaceutical composition comprising a compound, or pharmaceutically acceptable salt thereof, of formula
- wherein R1 is —S—CH3 or H.
Dependencies are inferred from the claim text.